Indeed, Kaplan–Meier analysis of the Gene Expression Omnibus BC dataset, containing gene-expression profiles from 1,809 BC patients (21), showed an association between low GPx2 mRNA in luminal B, HER2-enriched, Basal-like tumors, and poor patient survival (SI Appendix, Fig. S2C). The gene discussed is ERBB2; the disease is breast cancer.